IMMUNTOLERANZINDUKTOR

European patent · EP2873417 · In force

Register entry

Publication number
EP2873417
Application number
EP13816500
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 3, 2013
Published
May 20, 2015
Granted
Mar 6, 2019
Protection ends at the latest
Jul 2, 2033
Next annual fee due
Jul 31, 2026
IPC classes
A61K 31/197 (2006.01)
A61K 33/26 (2006.01)
A61K 38/19 (2006.01)
A61K 31/194 (2006.01)
A61P 37/08 (2006.01)
A61P 37/06 (2006.01)
A61P 17/00 (2006.01)
Priority
JP 2012157374 13.07.2012
PCT application
PCT/JP2013/004130 03.07.2013
PCT publication
WO2014/010206 16.01.2014
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  5. Mar 6, 2019

    Granted

    Published in Swissreg on 06.03.2019

Parties

Holder

National Center for Child Health and Development

National Center For Child Health And Development

10-1 Okura 2-chome Setagaya-ku, Tokyo 157-8535, JP

SBI Pharmaceuticals Co., Ltd.

6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, JP

Inventor

ITO, Hidenori

Tokyo 106-6020, JP

HAGA, Naomi

Tokyo 106-6020, JP

RII, Ko

Tokyo 157-8535, JP

TANAKA, Tohru

Tokyo 106-6020, JP

TAKAHASHI, Kiwamu

Tokyo 106-6020, JP

NAKAJIMA, Motowo

Tokyo 106-6020, JP

ABE, Fuminori

Tokyo 106-6020, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.